CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Harbin Gloria Pharmaceuticals Co., Ltd Company Snapshot
Harbin Gloria Pharmaceuticals Co., Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Harbin Gloria Pharmaceuticals Co., Ltd with three other companies in this sector in China: Jiangsu Kanion Pharmaceutical Co., Ltd. (2015 sales of 2.82 billion Chinese Renmimbi [US$409.69 million] of which 100% was Exportation Trade), Shanghai Shyndec Pharmaceutical Co Ltd (2.68 billion Chinese Renmimbi [US$389.60 million] of which 74% was Drug Products), and Jiangzhong Pharmaceutical Company Limited (2.60 billion Chinese Renmimbi [US$377.10 million] of which 68% was Medical Industry).

Sales Analysis. Harbin Gloria Pharmaceuticals Co., Ltd reported sales of 2.70 billion Chinese Renmimbi (US$392.21 million) for the year ending December of 2015. This represents an increase of 41.7% versus 2014, when the company's sales were 1.91 billion Chinese Renmimbi. This was the fourth straight year of sales growth at Harbin Gloria Pharmaceuticals Co., Ltd. Sales of Pharmaceutical Research and Clinical Servi saw an increase that was more than double the company's growth rate: sales were up 93.1% in 2015, from 18.18 million Chinese Renmimbi to 35.10 million Chinese Renmimbi. Not all segments of Harbin Gloria Pharmaceuticals Co., Ltd experienced an increase in sales in 2015: sales of Other Operation fell 4.4% to 16.51 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Harbin Gloria Pharmaceuticals Co., Ltd
  Stock Performance Chart for Harbin Gloria Pharmaceuticals Co., Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 8.20
(Figures in Chinese Renmimbi)
1 Week -0.8%   13 Weeks -14.8%  
4 Weeks -0.2%   52 Weeks -13.7%  
 
Harbin Gloria Pharmaceuticals Co., Ltd Key Data:
  Ticker: 002437 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 2,700,073,753
(Year Ending Jan 2016).
Employees: 3,057
  Currency: Chinese Renmimbi Market Cap: 18,025,980,870
  Fiscal Yr Ends: December Shares Outstanding: 2,198,290,350
  Share Type: A Gu Closely Held Shares: 1,523,433,824
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.